Correspondence Address:
Dr.Bharati Nilkantha Zunjarrao Department Of Prasutitantra Streeroga B.R. Harne Ayurvedic Medical College Karav-Vangani Email: Bharatinzunjarrao@Gmail.Com
Date of Acceptance: 2023-10-02
Date of Publication:2023-10-10
Article-ID:AYU_100_10_23 https://ayuscript.com
Source of Support: Nill
Conflict of Interest: None declared
How To Cite This Article: Zunjarrao B.N. Clinical Efficacy of Bhunimbasharkara Vati in Garbhini Chhardi (Emesis Gravidarum). AYUSCRIPT 2023;2(3):62-70 DOI: http://doi.org/10.55552/AYUSCRIPT.2023.2307
Introduction: Vomiting in pregnancy is the first and foremost symptom of pregnancy. Emesis Gravidarum is a worldwide common obstetrical problem seen in the first trimester of pregnancy in about 50-60% of pregnant women. Ayurvedic classics have mentioned Garbhini Chardi as one among the Vyakta Garbha Lakshanas, which can be correlated with Emesis Gravidarum. The present study drug Subidhabala khand is used for the management of Garbhini chardi. Methodology: This single arm clinical trial study was conducted among 60 pregnant women pre and posttest design. The drugs of Bhunimba & Sharkara were collected in the form of raw material and BhunimbaSharkara Vati was prepared at GMP certified pharmacy. Drug Standardization and authentication was done before the clinical trial. These patients were selected based on the criteria of inclusion, exclusion and assessment were done as per the standard parameters. 60 patients were given BhunimbaSharkara Vati orally in a dose 500mg thrice a day before food with jala as Anupana from 8th to 14th week of pregnancy. The response to the treatment was recorded and therapeutic effects were evaluated by symptomatic relief and based on assessment criteria. Aim: To evaluate the therapeutic efficacy of BhunimbaSharkara Vati in Garbhini Chhardi. Objective: To observe the add-on benefits of BhunimbaSharkara Vati in relieving the symptomatology of Garbhini Chardi and its effect on fetal and maternal wellbeing. Result: In the present study, BhunimbaSharkara Vati was having good effect in reducing Chardi, relief was found and adverse effects were observed during the study period. Conclusion: In these, 6 patients taken irregular medicine and given irregular follow up were withdrawal, 1 patient was having missed abortion in 10 th week after 2nd follow up hence withdrawal, 1 patient was detected as GDM as raised Bsl, 2 patients was given allopathic treatment after 2 follow up as symptoms was not relieved hence withdrawal, Rest 60 patients had given regular follow up hence in the study significant improvement (P<0.005) was observed in symptomatology.
KEYWORDS: Emesis gravidarum, Garbhini Chardi, bhunimbasharkara vati.
